Name
Coverage of Addiction Benefits in ACA Plans
Date & Time
Tuesday, April 3, 2018, 3:45 PM - 5:00 PM
Speakers
Description
Moderator: Michelle C. Landers, JD, Vice President & General Counsel, Kentucky Employers’ Mutual Insurance, and Member, National Rx Drug Abuse & Heroin Summit Advisory Board
CE Certified By: AMA,AAFP,ACPE,ANCC,APA,NAADAC,NASW
The National Center on Addiction and Substance Abuse conducts comprehensive reviews of the addiction benefits offered in each state’s individual marketplace health insurance plans. Plans are evaluated for compliance with the Affordable Care Act’s requirements to cover addiction benefits and the adequacy of coverage for the full range of critical benefits to treat and manage addiction.
This presentation will provide an overview of the requirements to cover addiction treatment and present findings from the Center’s new review of 2017 ACA plans which will detail the specific benefits offered in each state. There will be a particular focus on coverage of medication assisted treatment for opioid addiction. The presenter will discuss recommendations developed by the Center to improve insurance coverage of evidence-based treatment and provide an update on federal healthcare reform to describe how any proposed or actual changes will impact insurance coverage for addiction treatment.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Identify the federal requirements to cover addiction benefits.
- Recognize the critical benefits needed for evidence-based addiction treatment and identify where coverage gaps typically occur.
- Describe actions that states can take to ensure comprehensive coverage of addiction benefits by plans sold in their state.
CE Certified By: AMA,AAFP,ACPE,ANCC,APA,NAADAC,NASW
The National Center on Addiction and Substance Abuse conducts comprehensive reviews of the addiction benefits offered in each state’s individual marketplace health insurance plans. Plans are evaluated for compliance with the Affordable Care Act’s requirements to cover addiction benefits and the adequacy of coverage for the full range of critical benefits to treat and manage addiction.
This presentation will provide an overview of the requirements to cover addiction treatment and present findings from the Center’s new review of 2017 ACA plans which will detail the specific benefits offered in each state. There will be a particular focus on coverage of medication assisted treatment for opioid addiction. The presenter will discuss recommendations developed by the Center to improve insurance coverage of evidence-based treatment and provide an update on federal healthcare reform to describe how any proposed or actual changes will impact insurance coverage for addiction treatment.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Identify the federal requirements to cover addiction benefits.
- Recognize the critical benefits needed for evidence-based addiction treatment and identify where coverage gaps typically occur.
- Describe actions that states can take to ensure comprehensive coverage of addiction benefits by plans sold in their state.